1-17 of 17
Geoffrey L. Uy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy

Clinical Trials & Observations
Geoffrey L. Uy, Vinod Pullarkat, Praneeth Baratam, Robert K. Stuart, Roland B. Walter, Eric S. Winer, Qi Wang, Stefan Faderl, Divya Chakravarthy, Diane Menno, Ronald S. Cheung, Tara L. Lin
Journal: Blood Advances
Blood Adv (2024) 8 (24): 6248–6256.
https://doi.org/10.1182/bloodadvances.2024013687
Published: 2024
Includes: Supplemental data
Journal Articles

Deficit accumulation frailty index (DAFI) and treatment tolerability in AML: Data from CALGB 11001 and 11002 (Alliance)

Clinical Trials & Observations
Catherine Lai, Minji Lee, Olivia Bobek, Jennifer Le-Rademacher, Sumithra J Mandrekar, Gail J. Roboz, Geoffrey L Uy, Jeanne Mandelblatt, Heidi D Klepin
Journal: Blood Advances
Blood Adv bloodadvances.2024014367.
https://doi.org/10.1182/bloodadvances.2024014367
Published: 2024
Journal Articles

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

Clinical Trials & Observations
Zachary D. Crees, Michael P. Rettig, Asad Bashey, Steven M. Devine, Samantha Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Brenda J. Grossman, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5210–5214.
https://doi.org/10.1182/bloodadvances.2023010407
Published: 2023
Includes: Supplemental data
Journal Articles

Association of social deprivation with survival in younger adult patients with AML: an Alliance study

Clinical Trials & Observations
Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, James S. Blachly, Shelley Orwick, Karilyn T. Larkin, Christopher C. Oakes, Andrew Hantel, Andrew J. Carroll, William G. Blum, Bayard L. Powell, Geoffrey L. Uy, Richard M. Stone, Richard A. Larson, John C. Byrd, Electra D. Paskett, Jesse J. Plascak, Ann-Kathrin Eisfeld
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4019–4023.
https://doi.org/10.1182/bloodadvances.2022009325
Published: 2023
Includes: Supplemental data
Journal Articles

Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma

Erica K. Barnell, Zachary L. Skidmore, Kenneth F. Newcomer, Monique Chavez, Katie M. Campbell, Kelsy C. Cotto, Nicholas C. Spies, Marianna B. Ruzinova, Tianjiao Wang, Brooj Abro, Friederike Kreisel, Bijal A. Parikh, Eric J. Duncavage, John L. Frater, Yi-Shan Lee, Anjum Hassan, Justin A. King, Daniel R. Kohnen, Mark A. Fiala, John S. Welch, Geoffrey L. Uy, Kiran Vij, Ravi Vij, Malachi Griffith, Obi L. Griffith, Lukas D. Wartman
Journal: Blood Advances
Blood Adv (2023) 7 (2): 236–245.
https://doi.org/10.1182/bloodadvances.2022007496
Published: 2023
Includes: Supplemental data
Journal Articles

Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML

Clinical Trials & Observations
Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Stuart L. Goldberg, Matthew J. Wieduwilt, Robert J. Ryan, Stefan Faderl, Jeffrey E. Lancet
Journal: Blood Advances
Blood Adv (2022) 6 (17): 4989–4993.
https://doi.org/10.1182/bloodadvances.2021006468
Published: 2022
Includes: Supplemental data
Journal Articles

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

Jingyu Xiang, Min Shi, Mark A. Fiala, Feng Gao, Michael P. Rettig, Geoffrey L. Uy, Mark A. Schroeder, Katherine N. Weilbaecher, Keith E. Stockerl-Goldstein, Shamim Mollah, John F. DiPersio
Journal: Blood Advances
Blood Adv (2022) 6 (7): 1991–2000.
https://doi.org/10.1182/bloodadvances.2021005149
Published: 2022
Includes: Supplemental data
Journal Articles

Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL

Clinical Trials & Observations
Matthew J. Wieduwilt, Jun Yin, Meir Wetzler, Geoffrey L. Uy, Bayard L. Powell, Jonathan E. Kolitz, Michaela Liedtke, Wendy Stock, Jan H. Beumer, Ryan J. Mattison, Elizabeth Storrick, Susan M. Christner, Lionel D. Lewis, Steven Devine, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4691–4700.
https://doi.org/10.1182/bloodadvances.2021004813
Published: 2021
Includes: Supplemental data
Journal Articles

Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses

Clinical Trials & Observations
Tara L. Lin, David A. Rizzieri, Daniel H. Ryan, Gary J. Schiller, Jonathan E. Kolitz, Geoffrey L. Uy, Donna E. Hogge, Scott R. Solomon, Matthew J. Wieduwilt, Robert J. Ryan, Stefan Faderl, Jorge E. Cortes, Jeffrey E. Lancet
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1719–1728.
https://doi.org/10.1182/bloodadvances.2020003510
Published: 2021
Includes: Supplemental data
Journal Articles

Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia

Clinical Trials & Observations
Christopher J. Walker, Krzysztof Mrózek, Hatice Gulcin Ozer, Deedra Nicolet, Jessica Kohlschmidt, Dimitrios Papaioannou, Luke K. Genutis, Marius Bill, Bayard L. Powell, Geoffrey L. Uy, Jonathan E. Kolitz, Andrew J. Carroll, Richard M. Stone, Ramiro Garzon, John C. Byrd, Ann-Kathrin Eisfeld, Albert de la Chapelle, Clara D. Bloomfield
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1474–1482.
https://doi.org/10.1182/bloodadvances.2020003727
Published: 2021
Includes: Supplemental data
Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Clinical Trials & Observations
Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3180–3190.
https://doi.org/10.1182/bloodadvances.2019001266
Published: 2020
Includes: Supplemental data
Journal Articles

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

Clinical Trials & Observations
Guido Marcucci, Susan Geyer, Kristina Laumann, Weiqiang Zhao, Donna Bucci, Geoffrey L. Uy, William Blum, Ann-Kathrin Eisfeld, Timothy S. Pardee, Eunice S. Wang, Wendy Stock, Jonathan E. Kolitz, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2020) 4 (4): 696–705.
https://doi.org/10.1182/bloodadvances.2019000492
Published: 2020
Journal Articles

Clinical and functional significance of circular RNAs in cytogenetically normal AML

Clinical Trials & Observations
Dimitrios Papaioannou, Stefano Volinia, Deedra Nicolet, Michał Świerniak, Andreas Petri, Krzysztof Mrózek, Marius Bill, Felice Pepe, Christopher J. Walker, Allison E. Walker, Andrew J. Carroll, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Bayard L. Powell, Geoffrey L. Uy, Jonathan E. Kolitz, Eunice S. Wang, Sakari Kauppinen, Adrienne Dorrance, Richard M. Stone, John C. Byrd, Clara D. Bloomfield, Ramiro Garzon
Journal: Blood Advances
Blood Adv (2020) 4 (2): 239–251.
https://doi.org/10.1182/bloodadvances.2019000568
Published: 2020
Includes: Supplemental data
Journal Articles

Evaluation of event-free survival as a robust end point in untreated acute myeloid leukemia (Alliance A151614)

Clinical Trials & Observations
Jun Yin, Betsy LaPlant, Geoffrey L. Uy, Guido Marcucci, William Blum, Richard A. Larson, Richard M. Stone, Sumithra J. Mandrekar
Journal: Blood Advances
Blood Adv (2019) 3 (11): 1714–1721.
https://doi.org/10.1182/bloodadvances.2018026112
Published: 2019
Includes: Supplemental data
Journal Articles

A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG - CPSF6 fusion

Clinical Trials & Observations
Christopher A. Miller, Christopher Tricarico, Zachary L. Skidmore, Geoffrey L. Uy, Yi-Shan Lee, Anjum Hassan, Michelle D. O’Laughlin, Heather Schmidt, Ling Tian, Eric J. Duncavage, Malachi Griffith, Obi L. Griffith, John S. Welch, Lukas D. Wartman
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1295–1299.
https://doi.org/10.1182/bloodadvances.2017014183
Published: 2018
Includes: Supplemental data
Journal Articles

A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3 -mutated acute myeloid leukemia: CALGB 11001

Clinical Trials & Observations
Geoffrey L. Uy, Sumithra J. Mandrekar, Kristina Laumann, Guido Marcucci, Weiqiang Zhao, Mark J. Levis, Heidi D. Klepin, Maria R. Baer, Bayard L. Powell, Peter Westervelt, Daniel J. DeAngelo, Wendy Stock, Ben Sanford, William G. Blum, Clara D. Bloomfield, Richard M. Stone, Richard A. Larson
Journal: Blood Advances
Blood Adv (2017) 1 (5): 331–340.
https://doi.org/10.1182/bloodadvances.2016003053
Published: 2017
Journal Articles

US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL

Clinical Trials & Observations
Farhad Ravandi, Megan Othus, Susan M. O'Brien, Stephen J. Forman, Chul S. Ha, Jeffrey Y. C. Wong, Martin S. Tallman, Elisabeth Paietta, Janis Racevskis, Geoffrey L. Uy, Mary Horowitz, Naoko Takebe, Richard Little, Uma Borate, Partow Kebriaei, Laura Kingsbury, Hagop M. Kantarjian, Jerald P. Radich, Harry P. Erba, Frederick R. Appelbaum
Journal: Blood Advances
Blood Adv (2016) 1 (3): 250–259.
https://doi.org/10.1182/bloodadvances.2016001495
Published: 2016
Includes: Supplemental data